Unicycive Therapeutics was included in the Russell Microcap Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNCY:
- Unicycive Therapeutics Joins Russell Microcap® Index
- Unicycive Therapeutics Reports Clinical Trial Breakthrough
- Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
- Unicycive Therapeutics achieves study objective in OLC clinical trial
- Unicycive Therapeutics delivers presentations on OLC, UNI-494